Bicocca Open Archive

Logo unimib boa
CORDANI, NICOLETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.627
AS - Asia 3.491
EU - Europa 2.733
SA - Sud America 467
AF - Africa 68
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 11.398
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.496
SG - Singapore 1.095
IT - Italia 1.035
CN - Cina 754
VN - Vietnam 604
HK - Hong Kong 427
RU - Federazione Russa 361
BR - Brasile 345
DE - Germania 241
SE - Svezia 208
IE - Irlanda 199
FR - Francia 148
IN - India 134
GB - Regno Unito 127
UA - Ucraina 101
CA - Canada 82
KR - Corea 81
ID - Indonesia 67
FI - Finlandia 61
BD - Bangladesh 49
NL - Olanda 48
TR - Turchia 45
ES - Italia 44
AR - Argentina 42
JP - Giappone 42
PL - Polonia 40
IQ - Iraq 38
MX - Messico 30
PK - Pakistan 26
ZA - Sudafrica 25
CH - Svizzera 24
AT - Austria 23
SA - Arabia Saudita 21
VE - Venezuela 19
EC - Ecuador 18
PH - Filippine 17
CO - Colombia 16
UZ - Uzbekistan 15
DK - Danimarca 14
BE - Belgio 12
LT - Lituania 12
JO - Giordania 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
KE - Kenya 9
MA - Marocco 9
AL - Albania 8
AU - Australia 7
EG - Egitto 6
MY - Malesia 6
PE - Perù 6
TH - Thailandia 6
BO - Bolivia 5
IR - Iran 5
KZ - Kazakistan 5
NP - Nepal 5
PS - Palestinian Territory 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
EU - Europa 4
JM - Giamaica 4
LB - Libano 4
MT - Malta 4
OM - Oman 4
RO - Romania 4
GR - Grecia 3
MU - Mauritius 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
BB - Barbados 2
BY - Bielorussia 2
CR - Costa Rica 2
CY - Cipro 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
ET - Etiopia 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
DM - Dominica 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KH - Cambogia 1
LC - Santa Lucia 1
LY - Libia 1
MG - Madagascar 1
MN - Mongolia 1
Totale 11.387
Salva come PNG Salva come JPEG
Città #
Singapore 639
Ann Arbor 574
Ashburn 496
Hong Kong 401
Milan 401
San Jose 374
Dallas 258
Woodbridge 219
Chandler 203
Dublin 193
Hanoi 179
Fairfield 168
New York 163
Ho Chi Minh City 153
Houston 153
Hefei 150
Frankfurt am Main 137
Los Angeles 128
Wilmington 109
Beijing 96
Jacksonville 93
Seattle 83
Santa Clara 79
Seoul 78
Chicago 72
Dearborn 69
The Dalles 68
Cambridge 62
Jakarta 55
São Paulo 46
Buffalo 42
Rome 41
Lauterbourg 40
Shanghai 40
Moscow 38
Princeton 38
Council Bluffs 37
Nanjing 37
Desio 34
Da Nang 33
Orem 32
Munich 30
Tokyo 29
Lissone 27
London 26
Warsaw 25
Helsinki 24
Montreal 23
Zurich 23
Denver 21
Nuremberg 20
Poplar 20
Baghdad 19
Mumbai 19
Paris 19
Stockholm 19
Atlanta 18
Boardman 18
Phoenix 18
Chennai 17
Haiphong 17
Lawrence 17
Kent 16
Seveso 16
Brooklyn 15
Lachine 15
Monza 15
Pune 14
Rio de Janeiro 14
Toronto 14
Amsterdam 13
Ankara 12
Brussels 12
Carate Brianza 12
Genoa 12
Hải Dương 12
Johannesburg 12
Nanchang 12
Salt Lake City 12
Biên Hòa 11
Bắc Ninh 11
San Diego 11
Tashkent 11
Turku 11
Altamura 10
Can Tho 10
Cinisello Balsamo 10
Lappeenranta 10
Ottawa 10
Riyadh 10
Shenyang 10
Tianjin 10
Vienna 10
Manchester 9
Seregno 9
Boston 8
Ha Long 8
Hangzhou 8
Nairobi 8
Quận Bình Thạnh 8
Totale 7.191
Salva come PNG Salva come JPEG
Nome #
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 519
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 451
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 421
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 408
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 388
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib 386
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 353
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 348
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 343
Primary cell cultures arising from normal kidney and renal cell carcinoma retain the proteomic profile of corresponding tissues 336
Conditioned Medium of Mesenchymal Stromal Cells Loaded with Paclitaxel Is Effective in Preclinical Models of Triple-Negative Breast Cancer (TNBC) 327
Chronic myeloid leukemia: Second-line drugs of choice 322
Expression of heat shock protein 27 in human renal cell carcinoma 319
Characterization of heat shock protein 27 phosphorylation sites in renal cell carcinoma 315
Differential Expression of NOTCH-1 and Its Molecular Targets in Response to Metronomic Followed by Conventional Therapy in a Patient with Advanced Triple-Negative Breast Cancer 303
Isolation of FAP Cells from Mouse Dystrophic Skeletal Muscle Using Fluorescence Activated Cell Sorting 295
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 278
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 275
Mutant p53 subverts p63 control over KLF4 expression in keratinocytes 261
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 256
Comparative proteomics of membrane microdomains from renal cell carcinoma and adiacent normal kidney 252
Proteolysis Targeting Chimera Agents (PROTACs): New Hope for Overcoming the Resistance Mechanisms in Oncogene-Addicted Non-Small Cell Lung Cancer 248
Comprehensive analysis of mutational processes across 20 000 adult and pediatric tumors 245
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 244
Co-targeting triple-negative breast cancer cells and endothelial cells by metronomic chemotherapy inhibits cell regrowth and migration via downregulation of the FAK/VEGFR2/VEGF axis and autophagy/apoptosis activation 235
Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 230
Nitric Oxide Controls Fat Deposition in Dystrophic Skeletal Muscle by Regulating Fibro-Adipogenic Precursor Differentiation 217
Malignant fibrous histiocytoma: a proposed cellular origin and identification of its characterizing gene transcripts 216
Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study 208
Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases 206
How to Treat HR+/HER2-Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story 204
Edaravone: A Novel Possible Drug for Cancer Treatment? 201
Metronomic Chemotherapy for Metastatic Breast Cancer Treatment: Clinical and Preclinical Data between Lights and Shadows 196
Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer 191
Abstract 987: Novel ALK mutations in EML4::ALK+ NSCLC resistant to TKIs identified by liquid biopsy 185
A Phase 2, Open Label, Multicenter, Single Arm Trial Evaluating the Activity and Safety of Abemaciclib + Aromatase Inhibitors (AIs) as Second-Line Treatment After First-Line Fulvestrant in Hormone-Receptor-Positive (HR+), Human-Epidermal-Growth-Factor-Receptor-Negative (HER2-) Metastatic Breast Cancer (MBC) Patients. Final Results of HERMIONE-7 Trial 184
Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease 177
The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFN alpha on pleomorphic sarcoma cells 173
Derangement of endothelial protein C receptor and thrombomodulin expression in the intestinal mucosa of patients with inflammatory bowel diseases 169
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons 167
Metronomic chemotherapy 166
EGFR overexpression in malignant pleural mesothelioma: An immunohistochemical and molecular study with clinico-pathological correlations 156
Investigation of the origin of malignant fibrous histiocytoma and identification of specific predictive markers for this tumour 144
Author Correction: Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer (npj Precision Oncology, (2025), 9, 1, (291), 10.1038/s41698-025-01088-0) 102
Totale 11.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.710
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202189 0 0 0 0 0 0 0 0 0 0 36 53
2021/2022293 30 42 48 32 8 21 13 15 11 19 21 33
2022/2023763 48 200 39 91 46 72 43 40 36 64 48 36
2023/2024906 50 50 32 51 115 187 146 40 53 39 41 102
2024/20252.210 121 181 147 120 191 88 140 56 224 321 188 433
2025/20265.404 652 498 528 709 669 284 905 242 407 490 20 0
Totale 11.620